Remote pregnancy outcome after leukocyte immunotherapy

Area of Science:

• Immunology
• Reproductive Medicine
• Obstetrics

Background:

• Recurrent miscarriage (RM) affects a significant number of women, impacting reproductive outcomes.
• Leukocyte immunotherapy has been explored as a treatment to improve live birth rates in women with RM.

Purpose of the Study:

• To evaluate the long-term efficacy of leukocyte immunotherapy in patients with recurrent miscarriage.
• To assess live birth rates in subsequent pregnancies following initial successful treatment.

Main Methods:

• A retrospective follow-up study of 28 patients who achieved live births after leukocyte immunization.
• Analysis of pregnancy outcomes in 16 of these patients who had subsequent pregnancies without further immunotherapy.

Main Results:

• Of the 16 patients with subsequent pregnancies, one was terminated, and five resulted in spontaneous abortion.
• A live birth rate of 10 out of 15 (67%) was observed in these subsequent pregnancies.
• The study suggests that the positive effects of leukocyte immunotherapy may not be sustained long-term.

Conclusions:

• While leukocyte immunotherapy may offer a temporary benefit in achieving live births for recurrent miscarriage patients, its long-lasting efficacy is questionable.
• Further research is needed to understand the durability of treatment effects and explore alternative or adjunctive therapies.